This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Manzi, S Articles by Salmon, J Search for Related Content PubMed PubMed Citation Articles by Manzi, S Articles by Salmon, J Social Bookmarking                         What's this?

New insights into complement: a mediator of injury and marker of disease activity in systemic lupus erythematosus

Lupus Center of Excellence, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA, sxm6{at}pitt.edu

J M Ahearn

Lupus Center of Excellence, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

J Salmon

Mary Kirkland Center for Lupus Research, Hospital for Special Surgery, Weill Medical College, Cornell University, New York, NY, USA, salmonj{at}hss.edu

Studies performed during the past several decades have demonstrated a role for the complement system in both the etiology and pathogenesis of systemic lupus erythematosus (SLE). However the specifically defective molecular and cellular pathways responsible for the disease and its complications have generally not been identified. In this report, we describe two recent advances in complement pathobiology that highlight future directions for promising investigation toward enhancing our capacity to diagnose SLE, to monitor activity of the disease, and to identify molecular and cellular defects in SLE that can be targeted by therapeuticinhibitors of complement activation.In the first example, we describe recently developed assays to detect erythrocyte C4d and complement receptor1 for diagnosis and monitoring of disease activity in SLE. In the second example, we describe a recently discovered role for complement in mediating fetal loss in antiphospholipid syndrome and discuss the potential for this observation to facilitate identification and development of complement based biomarkers to predict poor fetal outcome in pregnant patients with SLE. These two examples are meant to underscore the importance of complement in the etiology and pathogenesis of SLE and its complications, and to stress the need for further investigation focused on the link between the complement system and SLE.

Key Words: complement • complement activation • complement receptor 1 • lupus activity • pregnancy

Lupus, Vol. 13, No. 5, 298-303 (2004)
DOI: 10.1191/0961203303lu1016oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D.-H. Yang, D.-M. Chang, J.-H. Lai, F.-H. Lin, and C.-H. Chen Usefulness of erythrocyte-bound C4d as a biomarker to predict disease activity in patients with systemic lupus erythematosus Rheumatology, September 1, 2009; 48(9): 1083 - 1087. [Abstract] [Full Text] [PDF]

				S-J. Li, Z-H. Liu, C-H. Zen, Q-W. Wang, Y. Wang, and L-S. Li Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection Lupus, November 1, 2007; 16(11): 875 - 880. [Abstract] [PDF]

				J E Balow Clinical presentation and monitoring of lupus nephritis Lupus, January 1, 2005; 14(1): 25 - 30. [Abstract] [PDF]